Therapy News and Research

RSS

Bristol-Myers Squibb launches Daklinza in the UK for treatment of chronic hepatitis C

Bristol-Myers Squibb today announced the launch of Daklinza▼ (daclatasvir) in the UK, a new medicine for the treatment of adult patients with chronic hepatitis C. Daclatasvir, a treatment that works across multiple hepatitis C genotypes, will allow up to 90% of UK patients the option of a potentially curative oral treatment regimen that does not include interferon, a standard of care commonly associated with sustained flu-like side effects.

4 Sep 2014

Study shows 1 in 10 patients may not need surgery following heart attack

Researchers from the Golden Jubilee National Hospital and the University of Glasgow have reported a study that shows one in ten patients may not need cardiac intervention following a heart attack and in those that do need stents, the procedure can be targeted more effectively.

4 Sep 2014

ICBT might be equally effective alternative to conventional CBT in management of chronic tinnitus

Chronic tinnitus is a disabling disorder. A new study published in the current issue of Psychotherapy and Psychosomatics reports on a therapy that is performed over internet.

4 Sep 2014

New way to reduce abnormal blood vessel growth and leakage in eye

Working with mice, a multicenter team of researchers has found a new way to reduce the abnormal blood vessel growth and leakage in the eye that accompany some eye diseases. The finding could lead to the development of new drugs for wet macular degeneration and diabetic macular edema.

4 Sep 2014

Clinical trial to assess safety and efficacy of novel monoclonal antibody for CLL patients

Researchers at the University of California, San Diego School of Medicine, in partnership with the California Institute for Regenerative Medicine (CIRM) and Celgene Corporation, a New Jersey-based biopharmaceutical company, have launched a phase 1 human clinical trial to assess the safety and efficacy of a novel monoclonal antibody for patients with chronic lymphocytic leukemia (CLL).

4 Sep 2014

Scientists identify genetic mutations in endometrioid endometrial carcinoma

Parents of twins often tell them apart through subtle differences such as facial expression, moles, voice tone and gait. Similarly, physicians treating women with endometrial cancer must be able to distinguish between different versions of this disease form that, on the surface, appear the same.

4 Sep 2014

Electroconvulsive therapy combats treatment-resistant schizophrenia

The use of electroconvulsive therapy improves the chances of a treatment response in patients with continued schizophrenia symptoms despite use of antipsychotic medication, a randomised trial shows.

3 Sep 2014

One-two punch designed to knock out most dangerous brain cancer

University of Michigan Health System doctors have started testing a unique new approach to fighting brain tumors -- one that delivers a one-two punch designed to knock out the most dangerous brain cancer.

3 Sep 2014

Researchers examine role of blocking vagus nerve in weight loss

Among patients with morbid obesity, blocking the vagus nerve, which plays a role with appetite and metabolism, did not meet pre-specified efficacy objectives compared to a control group, although the intervention did result in greater weight loss, according to a study in the September 3 issue of JAMA.

3 Sep 2014

No added benefit determined from Mirabegron for mortality, morbidity and quality of life

Mirabegron (trade name: Betmiga) has been approved since December 2012 for the treatment of adults with overactive bladder.

3 Sep 2014

Clinical studies to treat unmet medical need post-transplantation

A class of biotechnology drugs called monoclonal antibodies is now being tested in clinical studies to treat an unmet medical need post-transplantation, called delayed graft function

3 Sep 2014

White pill may help scientists learn why patients with cystic fibrosis have less exercise capacity

A little white pill may help scientists learn why patients with cystic fibrosis have less exercise capacity than their peers, even if their lungs are relatively healthy.

3 Sep 2014

Novel polypill increases patient adherence to treatment following heart attack

New research shows a novel polypill increases patient adherence to treatment following a myocardial infarction (MI) or heart attack, according to new study results reported at the European Society of Cardiology's ESC Congress 2014 in Barcelona, Spain.

3 Sep 2014

Percentage of women undergoing double mastectomy increased, shows survey

Among women diagnosed with early-stage breast cancer in California, the percentage undergoing a double mastectomy increased substantially between 1998 and 2011, although this procedure was not associated with a lower risk of death than breast-conserving surgery plus radiation, according to a study in the September 3 issue of JAMA.

3 Sep 2014

BIOTRONIK Home Monitoring reduces mortality in heart failure patients, saves costs

Experts discussed the benefits of Home Monitoring technology from the perspective of patients, hospitals and payers for the first time at a press conference held by BIOTRONIK at the European Society of Cardiology’s annual congress, ESC Congress 2014.

3 Sep 2014

Researchers create new drug to reduce inflammation of donor organ after transplantation

To reduce the number of discards and thus make more kidneys available, researchers and medical scientists from the European consortium MABSOT have created a new drug called OPN-305 to reduce inflammation of the donor organ after transplantation.

3 Sep 2014

ANP reports primary efficacy results from ATL1103 Phase II trial in patients with acromegaly

Antisense Therapeutics Limited is pleased to report the primary efficacy results from its Phase II clinical trial of ATL1103 in patients with the potentially life threatening growth disorder, acromegaly.

2 Sep 2014

XBiotech reports interim results from Phase III study for anti-cancer agent Xilonix

XBiotech announced today interim results from its fast-tracked Phase III study being conducted in the US for its anti-cancer agent Xilonix.

2 Sep 2014

BioPhotas launches Celluma ELITE for sale to Aesthetic Physician Market

BioPhotas, Inc. today announced the launch of the Celluma ELITE for sale to the Aesthetic Physician Market. The LED therapy device is stand-mounted and able to be precisely positioned over an area of treatment via an articulating arm and a patented shape-taking light panel.

2 Sep 2014

Ampio updates phase III, multicenter, double-blind STEP study of Ampion for knee osteoarthritis

Ampio Pharmaceuticals, Inc. today announced an update on the phase III, multicenter, double-blind STEP study of Ampion™ for osteoarthritis of the knee.

2 Sep 2014

Therapy News and Research

Bristol-Myers Squibb launches Daklinza in the UK for treatment of chronic hepatitis C

Study shows 1 in 10 patients may not need surgery following heart attack

ICBT might be equally effective alternative to conventional CBT in management of chronic tinnitus

New way to reduce abnormal blood vessel growth and leakage in eye

Clinical trial to assess safety and efficacy of novel monoclonal antibody for CLL patients

Scientists identify genetic mutations in endometrioid endometrial carcinoma

Electroconvulsive therapy combats treatment-resistant schizophrenia

One-two punch designed to knock out most dangerous brain cancer

Researchers examine role of blocking vagus nerve in weight loss

No added benefit determined from Mirabegron for mortality, morbidity and quality of life

Clinical studies to treat unmet medical need post-transplantation

White pill may help scientists learn why patients with cystic fibrosis have less exercise capacity

Novel polypill increases patient adherence to treatment following heart attack

Percentage of women undergoing double mastectomy increased, shows survey

BIOTRONIK Home Monitoring reduces mortality in heart failure patients, saves costs

Researchers create new drug to reduce inflammation of donor organ after transplantation

ANP reports primary efficacy results from ATL1103 Phase II trial in patients with acromegaly

XBiotech reports interim results from Phase III study for anti-cancer agent Xilonix

BioPhotas launches Celluma ELITE for sale to Aesthetic Physician Market

Ampio updates phase III, multicenter, double-blind STEP study of Ampion for knee osteoarthritis

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News